CLINICAL_TRIALS
trial_result
· 2022-02-10
Clinical Trial Update: Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease [Phase 2]
Summary
Phase 2 trial assessing dexamethasone to prevent oral chronic graft-versus-host disease; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Graft vs Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-02-10